Cooper Companies | COO - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Abbott USD 4.68B 439M 2026-03
Align Technology USD 109.84M 13.88M 2026-06
AtriCure USD 78.74M 8.68M 2026-06
Bausch Health Companies USD 593M 0 2026-06
Baxter International USD 1.03B 52M 2026-06
Bayer EUR 6.39B 192M 2026-06
Becton, Dickinson and Co. USD 6.11B 173M 2026-06
Boston Scientific USD 1.23B 90M 2026-06
Cooper Companies USD 233.3M 7.5M 2026-03
Dentsply International USD 260M 1000K 2026-06
Dexcom USD 2.08B 134.8M 2026-06
Edwards Lifesciences USD 210.5M 29.4M 2026-06
Globus Medical USD 106.94M 3.28M 2026-06
Haemonetics USD 56.34M 5.28M 2026-06
Inogen USD 21.22M 684K 2025-09
Insulet USD 123.3M 26.5M 2026-06
Integra LifeSciences USD 82.64M 5.31M 2026-06
Intuitive Surgical USD 1.92B 66.6M 2026-06
J&J USD 9.22B 1.24B 2026-06
Medtronic USD 2.57B 12M 2025-12
Merit Medical Systems USD 70.74M 2.88M 2026-06
Novartis USD 4.32B 134M 2026-03
ResMed USD 308.92M 35.62M 2026-06
STAAR Surgical USD 13.48M 4.78M 2026-06
Steris USD 344.1M 5.3M 2026-06
Stryker USD 1.59B 207M 2026-03
Tandem Diabetes Care USD 64.13M 4.27M 2026-06
Teleflex USD 143.29M 335K 2026-06
Utah Medical Products USD 1.19M 283K 2026-03
Zimmer Biomet Holdings USD 352.4M 8.8M 2026-06